UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
Abstract Background Ubiquilin-4 (UBQLN4) is a member of the ubiquitin–proteasome system that is usually upregulated in many tumor cells. Its overexpression has been associated with poor disease outcomes in various cancer diseases. However, the underlying mechanism of UBQLN4 in the development of hep...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-019-1078-5 |
id |
doaj-f3e7d3e64b8b4a9598fcda5f8e822a2b |
---|---|
record_format |
Article |
spelling |
doaj-f3e7d3e64b8b4a9598fcda5f8e822a2b2021-01-03T12:09:17ZengBMCCancer Cell International1475-28672020-01-0120111310.1186/s12935-019-1078-5UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370Yan Yu0Penglin Xu1Guangying Cui2Xiaodong Xu3Kongfei Li4Xiaolong Chen5Jie Bao6Precision Medicine Center, The First Affiliated Hospital of Zhengzhou UniversityKey Laboratory of Clinical Medicine, Department of Digestive Diseases, The First Affiliated Hospital of Zhengzhou UniversityPrecision Medicine Center, The First Affiliated Hospital of Zhengzhou UniversityKey Laboratory of Clinical Medicine, Department of Digestive Diseases, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Hematology, Yinzhou People’s Hospital Affiliated to Medical College of Ningbo UniversityPrecision Medicine Center, The First Affiliated Hospital of Zhengzhou UniversityKey Laboratory of Clinical Medicine, Department of Digestive Diseases, The First Affiliated Hospital of Zhengzhou UniversityAbstract Background Ubiquilin-4 (UBQLN4) is a member of the ubiquitin–proteasome system that is usually upregulated in many tumor cells. Its overexpression has been associated with poor disease outcomes in various cancer diseases. However, the underlying mechanism of UBQLN4 in the development of hepatocellular carcinoma (HCC) has not been elucidated. Methods Immunochemistry, real-time PCR, and western blotting were used to evaluate the expression levels of UBQLN4 in cancer tissues. Univariate, Cox-regression, and Kaplan–Meier analyses were performed to determine the association between UBQLN4 expression and HCC prognosis. Cell Counting Kit-8 (CCK-8), transwell, EDU and colony formation assays were conducted to evaluate the role of UBQLN4 in HCC cell progression. The gene set enrichment analysis and luciferase reporter experiments were conducted to find the mechanism of UBQLN4 in HCC. Results Ubiquilin-4 (UBQLN4) was overexpressed in HCC tissues. Besides, overexpression of UBQLN4 was associated with poor overall survival and disease-free survival rate of HCC patients. The loss-of-function analysis revealed that suppression of UBQLN4 inhibited the proliferation and invasion of HCC cells in vivo and in vitro. The KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis showed that UBQLN4 could regulate activation of the wnt-β-catenin pathway in HCC cells. Furthermore, our results showed that UBQLN4 was downregulated by miR-370, which acted as a tumor suppressor gene in HCC progression. Conclusion The results of the present study suggest that the miR-370/UBQLN4 axis may play a critical role in the progression of HCC. These findings may inform future strategies for the development of therapeutic agents against HCC.https://doi.org/10.1186/s12935-019-1078-5Ubiquilin-4 (UBQLN4)Hepatocellular carcinoma (HCC)wnt-β-catenin pathwayMiR-370 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yan Yu Penglin Xu Guangying Cui Xiaodong Xu Kongfei Li Xiaolong Chen Jie Bao |
spellingShingle |
Yan Yu Penglin Xu Guangying Cui Xiaodong Xu Kongfei Li Xiaolong Chen Jie Bao UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370 Cancer Cell International Ubiquilin-4 (UBQLN4) Hepatocellular carcinoma (HCC) wnt-β-catenin pathway MiR-370 |
author_facet |
Yan Yu Penglin Xu Guangying Cui Xiaodong Xu Kongfei Li Xiaolong Chen Jie Bao |
author_sort |
Yan Yu |
title |
UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370 |
title_short |
UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370 |
title_full |
UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370 |
title_fullStr |
UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370 |
title_full_unstemmed |
UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370 |
title_sort |
ubqln4 promotes progression of hcc via activating wnt-β-catenin pathway and is regulated by mir-370 |
publisher |
BMC |
series |
Cancer Cell International |
issn |
1475-2867 |
publishDate |
2020-01-01 |
description |
Abstract Background Ubiquilin-4 (UBQLN4) is a member of the ubiquitin–proteasome system that is usually upregulated in many tumor cells. Its overexpression has been associated with poor disease outcomes in various cancer diseases. However, the underlying mechanism of UBQLN4 in the development of hepatocellular carcinoma (HCC) has not been elucidated. Methods Immunochemistry, real-time PCR, and western blotting were used to evaluate the expression levels of UBQLN4 in cancer tissues. Univariate, Cox-regression, and Kaplan–Meier analyses were performed to determine the association between UBQLN4 expression and HCC prognosis. Cell Counting Kit-8 (CCK-8), transwell, EDU and colony formation assays were conducted to evaluate the role of UBQLN4 in HCC cell progression. The gene set enrichment analysis and luciferase reporter experiments were conducted to find the mechanism of UBQLN4 in HCC. Results Ubiquilin-4 (UBQLN4) was overexpressed in HCC tissues. Besides, overexpression of UBQLN4 was associated with poor overall survival and disease-free survival rate of HCC patients. The loss-of-function analysis revealed that suppression of UBQLN4 inhibited the proliferation and invasion of HCC cells in vivo and in vitro. The KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis showed that UBQLN4 could regulate activation of the wnt-β-catenin pathway in HCC cells. Furthermore, our results showed that UBQLN4 was downregulated by miR-370, which acted as a tumor suppressor gene in HCC progression. Conclusion The results of the present study suggest that the miR-370/UBQLN4 axis may play a critical role in the progression of HCC. These findings may inform future strategies for the development of therapeutic agents against HCC. |
topic |
Ubiquilin-4 (UBQLN4) Hepatocellular carcinoma (HCC) wnt-β-catenin pathway MiR-370 |
url |
https://doi.org/10.1186/s12935-019-1078-5 |
work_keys_str_mv |
AT yanyu ubqln4promotesprogressionofhccviaactivatingwntbcateninpathwayandisregulatedbymir370 AT penglinxu ubqln4promotesprogressionofhccviaactivatingwntbcateninpathwayandisregulatedbymir370 AT guangyingcui ubqln4promotesprogressionofhccviaactivatingwntbcateninpathwayandisregulatedbymir370 AT xiaodongxu ubqln4promotesprogressionofhccviaactivatingwntbcateninpathwayandisregulatedbymir370 AT kongfeili ubqln4promotesprogressionofhccviaactivatingwntbcateninpathwayandisregulatedbymir370 AT xiaolongchen ubqln4promotesprogressionofhccviaactivatingwntbcateninpathwayandisregulatedbymir370 AT jiebao ubqln4promotesprogressionofhccviaactivatingwntbcateninpathwayandisregulatedbymir370 |
_version_ |
1724350774779052032 |